SMAD2 and colonic neoplasm: This interaction stimulates SMAD3 phosphorylation and activates the SMAD2-3-4 signaling pathway, resulting in the inhibition of cyclin D1/CDK4 expression and leading to G1 cell cycle arrest in colon cancer cells.